TerminatedPhase 2NCT00376337

Micafungin Salvage Mono-therapy in Invasive Aspergillosis

Studying Aspergillosis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Astellas Pharma Inc
Principal Investigator
Central Contact
Astellas Pharma Europe B.V.
Intervention
Micafungin(drug)
Enrollment
17 enrolled
Eligibility
18 years · All sexes
Timeline
20062008

Study locations (30)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00376337 on ClinicalTrials.gov

Other trials for Aspergillosis

Additional recruiting or active studies for the same condition.

See all trials for Aspergillosis

← Back to all trials